Back |
home / stock / cdtx / cdtx message board
Subject | By | Source | When |
---|---|---|---|
$CDTX: Nice Close here!!! | Invest-in-America | investorshub | 01/25/2023 9:13:16 PM |
Oh I see, thanks for the info. | DK11 | investorshub | 01/25/2023 8:22:27 PM |
$CDTX: In light of all of the OTHER | Invest-in-America | investorshub | 01/25/2023 8:07:54 PM |
Gonna run now, get ship ready!!! | DK11 | investorshub | 01/25/2023 7:49:34 PM |
$CDTX: It could run hard, given the extent | Invest-in-America | investorshub | 01/25/2023 2:18:18 PM |
$1.25 Open for business again lets go | tw0122 | investorshub | 01/25/2023 12:34:13 PM |
FDA Advisory Committee Recommends Approval of Rezafungin . | willlbone | investorshub | 01/25/2023 12:15:26 PM |
Seeking Alpha short sell attack. | willlbone | investorshub | 01/20/2023 6:28:59 PM |
Surprised that there is no action on this | now invest | investorshub | 01/17/2023 3:39:58 PM |
znewcar1: LOD.5601 on a sharp decline! would have to hit.69 for a turnaround! $CDTX | znewcar1 | investorshangout | 10/03/2022 4:06:35 PM |
znewcar1: ML.44 was sitting @.75 then a .7 sell off happened | znewcar1 | investorshangout | 07/28/2022 5:41:37 PM |
Monster Volume $CDTX | Golden Cross | investorshub | 07/28/2022 12:31:59 AM |
Cidara Therapeutics Submits NDA for Rezafungin and Announces | subslover | investorshub | 07/27/2022 12:19:39 PM |
H | CAJUN | investorshub | 12/19/2021 1:42:54 AM |
https://finance.yahoo.com/news/cidara-inks-licensing-collaboration-deal-09152896 | becaboo23 | investorshub | 04/06/2021 5:03:41 PM |
znewcar1: CDTX 23% v1,2M c2.52 f43,9M H2.71 S2.48 | znewcar1 | investorshangout | 11/13/2020 2:23:48 AM |
https://www.genengnews.com/virology/coronavirus/catching-up-to-coronavirus-top-6 | icroucher | investorshub | 03/19/2020 12:11:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients ...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...